Interferon-α induced lupus in a patient with chronic hepatitis C virus

Journal of Clinical Rheumatology

Volumn 17, Issue 3, 2011, Pages 152-153

  Rizvi, Rubina ^a   Hojjati, Mehrnaz ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; PEGINTERFERON ALPHA; PIMECROLIMUS; RIBAVIRIN;

ABDOMINAL PAIN; ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG WITHDRAWAL; FATIGUE; FEVER; FOLLOW UP; HEPATITIS C; HUMAN; LUPUS LIKE SYNDROME; LYMPHADENOPATHY; MALE; MESENTERY LYMPH NODE; PARAAORTIC LYMPH NODE; PHOTOSENSITIVITY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS; VIRUS LOAD;

ANTIRHEUMATIC AGENTS; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENTS; INTERFERON ALFA-2A; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; TACROLIMUS; TREATMENT OUTCOME;

EID: 79955062739     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31821557e7     Document Type: Article

References (28)

1. Wilson LE, Widman D, Dikman SH, et al. Autoimmune disease complicating antiviral therapy for HCV infection. Semin Arthritis Rheum. 2002;32:163-173. (Pubitemid 36043715)
2. Wandl UB, Nagel-Hiemke M, May D, et al. Lupus like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol. 1992;65:70-74.
3. Ronnblom LE, Alm GV, Oberg KE. Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour. J Intern Med. 1990;227:207-210. (Pubitemid 20075945)
4. Schilling PJ, Kurzrock R, Kantarjian H, et al. Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer. 1991;68:1536-1537.
5. Mehta ND, Hooberman AL, Vokes EE, et al. 35-year-old patient with chronic myelogenous leukemia. Am J Hematol. 1992;41:141.
6. Tolymat A, Leventhal B, Sakarcan A, et al. Systemic lupus erythematosus in a child receiving long-term interferon therapy. J Pediatr. 1992;120:429-432.
7. Hory B, Blanc D, Saint-Hiller Y. Systemic lupus erythematosus-like syndrome induced by alpha-interferon therapy. Eur J Med. 1992;1:379.
8. Flores A, Olive A, Feliu E, et al. Systemic lupus erythematosus following interferon therapy. Br J Rheumatol. 1994;33:787. (Pubitemid 24249194)
9. Yoshida A, Takeda A, Koyama K, et al. Systemic lupus erythematosus with nephropathy after interferon α 2A therapy. Clin Rheumatol. 1994;13:382.
10. Morris LF, Lemak NA, Arnett FC, et al. Systemic lupus erythematosus diagnosed during interferon α therapy. South Med J. 1996;89:810-814. (Pubitemid 26286686)
11. Fukuyama S, Kajiwara E, Suzuki N, et al. Systemic lupus erythematosus after α interferon therapy for chronic hepatitis C: a case report and review of the literature. Am J Gastroenterol. 2000;95:310.
12. Dominique P, Theissen F, Humbel R-L. Lupus syndrome, hypothyroidism and bullous skin lesions after interferon α therapy for hepatitis C in a haemodialysis patient. Nephrol Dial Transplant. 2002;17:174. (Pubitemid 34093038)
13. Goldman KE, Marshall MK, Alessandrini E, et al. Complications of α-interferon therapy for aggressive central giant cell lesion of the maxilla. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:285-291. (Pubitemid 41191338)
14. Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol. 2005;24:178-181. (Pubitemid 40552976)
15. Lodato F, Tame MR, Colecchia A, et al. Systemic lupus erythematosus following virological response to peg interferon α-2b in a transplanted patient with chronic hepatitis C recurrence. World J Gastroenterol. 2006;12:4253-4255. (Pubitemid 44376915)
16. Yilmaz S, Cimen KA. Pegylated interferon α-2B induced lupus in a patient with chronic hepatitis B virus infection. Clin Rheumatol. 2009;28:1241-1243.
17. Abbott IJ, Chang CC, Skinner MJ, et al. Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report. J Med Case Reports. 2009;3:7289.
18. Ho V, Mclean A, Terry S. Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C. J Clin Rheumatol. 2008;14:166-168.
19. Touzot M, Touzot F, Galicier L, et al. Polyarthritis and anemia in a hemodialysis patient: systemic lupus erythematosus following treatment with interferon alpha. Clin Nephrol. 2010;73:318-320.
20. Boonen A, Stockbrugger RW, van der Linden SJ. Pericarditis after therapy with interferon-α for chronic hepatitis. Clin Rheumatol. 1998;18:177-179.
21. García-Porrúa C, González-Gay MA, Fernández-Lamelo F, et al. Simultaneous development of SLE-like syndrome and autoimmune thyroiditis following α-interferon treatment. Clin Exp Rheumatol. 1998;16:107-108. (Pubitemid 28133498)
22. Borg FA, Isenberg DA. Syndromes and complications of interferon therapy. Curr Opin Rheumatol. 2007;19:61-66. (Pubitemid 44885729)
23. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277. (Pubitemid 13221242)
24. Hochberg, MC. Updating the American College of Rheumatology Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
25. Niewold TB. Interferon α-induced lupus proof of principle. J Clin Rheumatol. 2008;14:131-132.
26. Vallin H, Blomberg S, Alm GV, et al. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-α (IFN-α) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol. 1999;115:196-202. (Pubitemid 29030385)
27. Bauer JW, Petri M, Batliwalla FM, et al. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheum. 2009;60:3098-3107.
28. Kariuki SN, Franek BS, Kumar AA, et al. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther. 2010;12:R151.